pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 15·1 min read
save

U.S. officials urge Germany to raise drug prices in trade talks

May 15, 2026·read at STAT ↗RegulatoryNeutral

U.S. Trade Representative Jamieson Greer and senior health adviser Chris Klomp met with German Ambassador Jens Hanefeld at a breakfast briefing to press Germany to increase the price it pays for prescription medicines.

The officials suggested that the United States could invoke Section 301 tariffs, a trade tool used to counter practices deemed unfair, as leverage to compel higher drug payments abroad.

The German ambassador said he would take the proposal back to his government for consideration, but no agreement was reached during the meeting.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Top U.S. officials pressured Germany to pay more for prescription drugs”

read at STAT ↗
486 words · retrieved May 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTELLASUltragenyx Pharmaceutical Inc.
drugs
Rare Disease
topics
Approval2Gene Therapy (AAV)OncologyRare Disease

related stories

  • 2d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • May 12STAT+: Hims’ sales miss as telehealth competition growsSTAT
  • Apr 28STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data neededSTAT
  • Dec 23Fierce Biotech Layoff Tracker 2026: Caribou cuts staff, halts pipeline; Foghorn reduces workforce by 40%Fierce Biotech
  • Sep 2Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN dealsBioSpace